Other perinatal haematological disorders

P16_OTH_PERINA_HAEMATOL_DISORD

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — P61 Cause of death: ICD-10 — P61 2 out of 7 registries used, show all original rules.	61
4. Check minimum number of events None	61
5. Include endpoints None	61
6. Filter based on genotype QC (FinnGen only)	55

Control definitions (FinnGen only)

Control exclude: P16_HAEMORRHAGIC_HAEMATOL_DISORD_FETUS_NEWBO

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: P[5-6]
Name in latin: Aliae morbositates haematologicae perinatales

NAME	P16_OTH_PERINA_HAEMATOL_DISORD
CONTROL_EXCLUDE	P16_HAEMORRHAGIC_HAEMATOL_DISORD_FETUS_NEWBO
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	P61
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	P61
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other perinatal haematological disorders based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	3857	1614	2243
Only index persons	2091	866	1225
Unadjusted period prevalence (%)
Whole population	0.06	0.05	0.06
Only index persons	0.04	0.03	0.05
Median age at first event (years)
Whole population	-	0.00	0.00
Only index persons	0.00	0.00	0.00

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	55	31	24
Unadjusted period prevalence (%)	0.01	0.01	0.01
Median age at first event (years)	0.00	0.00	0.00

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
61: Matched controls
610

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

P61.1

ICD-10 Finland

Polycythaemia neonatorum

+∞

16.4

P61.0

ICD-10 Finland

Transient neonatal thrombocytopenia

+∞

16.4

Z87.6

ICD-10 Finland

Personal history of certain conditions arising in the perinatal period

22.4

16.3

P07.3

ICD-10 Finland

Other preterm infants

24.0

14.2

P61.4

ICD-10 Finland

Other congenital anaemias, not elsewhere classified

+∞

14.1

P61.2

ICD-10 Finland

Anaemia of prematurity

+∞

9.6

P61.3

ICD-10 Finland

Congenital anaemia from fetal blood loss

+∞

8.5

P70.4

ICD-10 Finland

Other neonatal hypoglycaemia

16.1

8.3

P22.1

ICD-10 Finland

Transient tachypnoea of newborn

16.4

7.2

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3020630) Protein [Mass/volume] in Serum or Plasma

3.31

1.47

1.2

3.3

64.84

59.65

g/l

—

(21494755) Public health laboratory ask at order entry panel

3.31

1.47

1.4

1.1

—

(3021589) Normoblasts [#/volume] in Blood

295

1.65

1.05

6.7

11.8

0.00

e9/l

-0.00

224

(3022313) Gas panel - Capillary blood

111

1.74

1.02

6.2

10.5

—

(40761511) CBC panel - Blood by Automated count

472

1.94

0.99

9.0

8.5

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.00

0.80

0.0

1.3

—

(3000494) Fungus identified in Specimen by Culture

1.95

0.77

1.6

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

0.51

0.74

1.2

2.1

—

(4035726) Immunohistochemistry procedure

1.93

0.70

1.0

1.8

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

514

0.63

0.69

4.0

3.9

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1.58

0.66

2.1

3.7

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

0.00

0.61

0.0

1.8

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

126

1.48

0.60

6.8

10.3

1.25

1.16

mmol/l

0.05

(3022621) pH of Urine by Test strip

0.00

0.59

0.0

2.1

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

0.00

0.59

0.0

15.0

—

0.30

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

140

0.66

0.51

2.8

2.2

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

0.57

0.50

2.8

1.6

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

102

0.65

0.44

1.6

2.3

—

(3024928) Oxygen saturation in Venous blood

0.00

0.42

0.0

37.3

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

0.00

0.42

0.0

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

0.00

0.41

0.0

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

0.00

0.41

0.0

1.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

0.00

0.40

0.0

1.1

—

(3045414) Leukocytes [Presence] in Urine

0.00

0.40

0.0

1.9

—

(42870560) Thyrotropin [Units/volume] in Cord blood

1.47

0.40

1.0

12.81

8.93

mu/l

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

487

1.46

0.40

7.6

11.5

28.96

21.68

mg/l

0.52

320

(3007853) Bacteria identified in Skin by Aerobe culture

1.36

0.39

2.0

1.7

—

(3016879) Cocaine [Presence] in Urine

1.33

0.39

1.0

1.7

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

143

0.72

0.37

3.9

2.7

—

(3027944) Amphetamines [Presence] in Urine

1.44

0.37

1.0

1.7

—

(3000764) Benzodiazepines [Presence] in Urine

1.44

0.37

1.0

1.7

—

(40768804) Tissue Pathology biopsy report

1.40

0.37

1.4

1.7

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1.40

0.35

4.7

9.1

1239.00

1613.03

ng/l

—

(3027008) Opiates [Presence] in Urine

1.42

0.35

1.0

1.7

—

(3028300) Cannabinoids [Presence] in Urine

1.42

0.35

1.0

1.7

—

(3013115) Eosinophils [#/volume] in Blood

304

1.27

0.34

6.5

10.9

0.16

0.22

e9/l

1.19

250

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

237

1.25

0.31

9.8

14.1

1.23

mmol/l

0.35

223

(3000991) Gas panel - Venous blood

113

1.31

0.30

5.6

15.4

—

(3044640) Blood type and Crossmatch panel - Blood

115

1.28

0.26

2.4

3.6

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

157

0.78

0.26

2.0

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

135

0.77

0.25

3.3

2.5

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

0.75

0.24

1.3

1.8

—

(3002032) Base excess in Venous blood by calculation

126

1.25

0.24

4.2

13.4

-0.43

0.99

mmol/l

0.47

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

102

0.75

0.23

2.5

1.8

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

1.27

0.23

1.2

1.5

—

(3012544) pH of Venous blood

127

1.24

0.22

4.3

13.3

—

(40767503) Oxygen content in Capillary blood by calculation

0.00

0.21

0.0

2.1

—

18.53

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

0.00

0.21

0.0

6.4

—

(3036180) Methadone [Presence] in Urine

0.00

0.21

0.0

2.3

—

(3016018) Differential panel - Cerebral spinal fluid

0.00

0.21

0.0

7.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

0.00

0.21

0.0

2.5

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.0

—

1.47

—

(3024471) HLA-A [Type]

0.00

0.21

0.0

1.0

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

0.00

0.21

0.0

1.2

—

0.74

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

6.2

—

2.46

—

(3024932) HLA-DR beta [Type]

0.00

0.21

0.0

1.1

—

(3011648) Oxygen content in Venous blood

0.00

0.21

0.0

45.3

—

11.21

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

324

1.19

0.21

7.7

11.6

3.69

3.35

e9/l

0.20

267

(3014051) Protein [Presence] in Urine by Test strip

0.00

0.21

0.0

2.2

—

(3034770) Mitochondria Ab [Titer] in Serum

0.00

0.20

0.0

2.1

—

(3011897) Casein IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.7

—

4.01

—

(3018405) Lactate [Moles/volume] in Arterial blood

0.00

0.20

0.0

3.6

—

1.89

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.00

0.20

0.0

1.0

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.20

0.0

1.3

—

(3019230) Fractional oxyhemoglobin in Venous blood

0.00

0.20

0.0

39.5

—

71.76

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

148

1.21

0.19

7.1

16.0

24.71

24.84

mmol/l

0.10

148

(3007164) IgA [Mass/volume] in Serum or Plasma

223

0.85

0.18

2.2

1.6

1.47

1.57

g/l

—

112

(3011397) Hemoglobin [Presence] in Urine by Test strip

119

0.81

0.17

3.0

4.0

—

(3023368) Bacteria identified in Blood by Culture

0.73

0.16

2.2

4.0

—

(3006315) Basophils [#/volume] in Blood

298

1.16

0.16

6.3

10.0

0.04

e9/l

0.05

242

(3001604) Monocytes [#/volume] in Blood

298

1.16

0.16

6.3

10.0

0.59

0.54

e9/l

0.28

242

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

261

0.87

0.15

1.7

2.2

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1.23

0.15

1.4

3.3

48.00

61.61

u/l

—

(3003694) ABO and Rh group [Type] in Blood

148

0.85

0.14

1.6

1.7

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

123

1.18

0.14

4.2

11.7

22.14

23.43

mmol/l

0.55

123

(3044889) 12 lead EKG panel

178

0.86

0.13

1.5

2.1

—

(3037467) Urinalysis macro (dipstick) panel - Urine

271

1.13

0.13

3.6

4.3

—

(3013512) EKG study

1.15

0.10

4.2

3.6

—

(3011288) Drugs identified in Urine by Screen method

1.15

0.09

1.0

2.2

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

174

0.89

0.09

3.3

4.9

—

(3033658) Prothrombin time (PT) actual/Normal

127

1.13

0.09

3.4

10.6

84.43

86.13

0.08

127

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1.04

0.08

1.0

1.4

1.08

1.37

—

(3018095) Leukocytes [#/volume] in Urine

188

1.09

0.06

4.0

5.7

5.56

27.31

e6/l

2.14

125

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

160

1.09

0.05

2.2

3.4

—

(40758558) Short blood count panel - Blood

180

0.92

0.04

9.2

8.3

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

230

0.93

0.04

2.3

1.9

2.10

3.07

u/ml

—

(40760892) CBC W Ordered Manual Differential panel - Blood

283

1.05

0.01

5.8

10.6

—

(3026008) Bacteria identified in Urine by Culture

113

0.97

0.00

1.5

2.9

—

(36660697) Celiac disease serology panel - Serum

105

1.06

0.00

1.0

1.2

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

124

0.96

0.00

1.1

3.7

—

(36304419) Bacteria [Presence] in Urine

154

0.97

0.00

3.5

4.8

—

(3001019) Free T4 and TSH panel - Serum or Plasma

0.00

0.0

2.3

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.00

0.0

1.5

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

0.00

0.0

8.8

—

24.08

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

0.00

0.0

2.8

—

4.19

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

0.00

0.0

1.0

—

113.67

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.00

0.0

1.2

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

0.00

0.0

1.5

—

151.17

—

(3041806) Other cells [#/volume] in Blood by Manual count

0.00

0.0

1.7

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

0.00

-0.00

0.0

1.1

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

0.00

-0.00

0.0

5.4

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.0

—

(3005011) Chlamydia sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.4

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

210

1.00

-0.00

2.6

6.5

19.14

28.39

u/l

1.01

203

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.00

-0.00

0.0

5.4

—

(3036071) Salmonella sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1.00

-0.00

1.5

1.9

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

5.60

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

15.4

—

8.01

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.0

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

0.00

-0.00

0.0

1.0

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.1

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

38.6

—

0.75

—

(3040151) Glucose [Moles/volume] in Capillary blood

0.00

-0.00

0.0

1.4

—

6.14

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

0.00

-0.00

0.0

1.4

—

37.80

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

0.00

-0.00

0.0

2.0

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

0.00

-0.00

0.0

1.2

—

91.60

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

0.00

-0.00

0.0

2.0

—

(4062490) Immunoglobulin typing, IgG

0.00

-0.00

0.0

1.1

—

(3013290) Carbon dioxide [Partial pressure] in Blood

0.00

-0.00

0.0

1.8

—

4.83

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

0.00

-0.00

0.0

2.0

—

(3029075) Extractable nuclear Ab panel - Serum

0.00

-0.00

0.0

1.0

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

0.00

-0.00

0.0

4.2

—

52.40

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

0.00

-0.00

0.0

2.0

—

(3022806) Fractional oxyhemoglobin in Capillary blood

0.00

-0.00

0.0

2.0

—

94.21

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.0

—

(3027315) Oxygen [Partial pressure] in Blood

0.00

-0.00

0.0

1.8

—

8.67

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

0.00

-0.00

0.0

1.1

—

2.33

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.00

-0.00

0.0

7.4

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

0.00

-0.00

0.0

1.0

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

121.86

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

0.00

-0.00

0.0

4.2

—

2.72

—

(3041096) Erythrocytes [Presence] in Urine by Automated

0.90

-0.00

1.1

3.0

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

0.00

-0.00

0.0

2.2

—

8.14

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

0.00

-0.00

0.0

1.1

—

5.81

—

(3026389) Candida sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.0

—

(3043409) Potassium [Moles/volume] in Arterial blood

0.00

-0.00

0.0

1.4

—

3.92

—

(40768441) Liver Pathology biopsy report

0.00

-0.00

0.0

2.7

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

0.00

-0.00

0.0

1.0

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.6

—

57.40

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.0

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

143.20

—

(3028271) Lactate [Moles/volume] in Capillary blood

0.00

-0.00

0.0

1.9

—

2.12

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

1.02

-0.00

1.0

1.7

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.4

—

23.71

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

0.00

-0.00

0.0

1.0

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

0.00

-0.00

0.0

1.4

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.0

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.0

—

(3016031) Almond IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

2.98

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

0.00

-0.00

0.0

1.0

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

2.8

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.4

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

0.00

-0.00

0.0

1.1

—

92.33

—

Mortality – FinRegistry

↥

Association

Association between endpoint P16_OTH_PERINA_HAEMATOL_DISORD and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have P16_OTH_PERINA_HAEMATOL_DISORD.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: P16_OTH_PERINA_HAEMATOL_DISORD – Other perinatal haematological disorders

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other perinatal haematological disorders

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints